Neoadjuvant immunology therapy in patients with non-small cell lung cancer and chronic obstructive pulmonary disease
For resectable NSCLC patients with COPD, neoadjuvant immunotherapy could achieve better pathological response, survival benefit and improve patients' lung function.
Authors
- Tianqing Chu (ORCID: https://orcid.org/0000-0002-0744-0397)
- Jiaqi Li (ORCID: https://orcid.org/0000-0001-9038-9010)
- Qing Chang
- Yinchen Shen (ORCID: https://orcid.org/0000-0002-1214-711X)
- Shuyuan Wang (ORCID: https://orcid.org/0000-0001-9686-5022)
- Yan Zhu (ORCID: https://orcid.org/0009-0002-1871-1380)
- Jialin Qian
- Huiping Qiang
- Haijiao Lu
Institutions
- Shanghai Jiao Tong University (CN)
- Shanghai Chest Hospital (CN)
Publication Details
- Journal
- Journal of Thoracic Disease
- Published
- 2024-11-01
- DOI
- https://doi.org/10.21037/jtd-24-811
- Citations
- 2
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.57
Funders
- National Health Commission of the People's Republic of China